The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women

Journal of Nutrition

Volumn 132, Issue 10, 2002, Pages 3036-3041

  McCann, Susan E ^a,b,c,d   Moysich, Kirsten B ^b   Freudenheim, Jo L ^a,b,c,d   Ambrosone, Christine B ^c   Shields, Peter G ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; CYP17; Humans; Phytoestrogens

Indexed keywords

CYTOCHROME P450C17; ENTERODIOL; ENTEROLACTONE; ESTROGEN; LIGNAN; PHYTOESTROGEN;

ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ESTROGEN METABOLISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREMENOPAUSE;

EID: 0036790101     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.10.3036     Document Type: Article

References (34)

1. Setchell, K.D.R. & Adlercreutz, H. (1988) Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism, and biological role in health and disease. In: Role of the Gut Flora in Toxicity and Cancer (Rowland, I., ed.). Academic Press, London, UK.
2. Hutchins, A. M., Lampe, J. W., Martini, M. C., Campbell, D. R. & Slavin, J. L. (1995) Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. J. Am. Diet. Assoc. 95: 769-774.
3. Adlercreutz, H., Mousavi, Y., Clark, J., Höckerstedt, K., Hämäläinen, E., Wähälä, K., Mäkelä, T. & Hase, T. (1992) Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 41: 331-337.
4. Haggans, C. J., Hutchins, A. M., Olson, B. A., Thomas, W., Martini, M. C. & Slavin, J. L. (1999) Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr. Cancer 33: 188-195.
5. Ursin, G., London, S., Stanczyk, F. Z., Gentzschein, E., Paganini-Hill, A., Ross, R. K. & Pike, M. C. (1998) A pilot study of urinary estrogen metabolites (16α-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ. Health Perspect. 106: A126-A127.
6. Ursin, G., London, S., Stanczyk, F. Z., Gentzschein, E., Paganini-Hill, A., Ross, R. K. & Pike, M. C. (1999) Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 91: 1067-1072.
7. Gupta, M., McDougal, A. & Safe, S. (1998) Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67: 413-419.
8. Meilahn, E. N., DeStavola, B., Allen, D. S., Fentiman, I., Bradlow, H. L., Sepkovic, D. W. & Kuller, L.H. (1998) Do urinary oestrogen metabolites predict breast cancer? Br. J. Cancer 78: 1250-1255.
9. Kabat, G. C., Chang, C. J., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A., Rosenblatt, R. & Bradlow, H. L. (1997) Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 6: 505-509.
10. Pietinen, P., Stumpf, K., Mannisto, S., Kataja, V., Uusitupa, M. & Adlercreutz, H. (2001) Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol. Biomarkers Prev. 10: 339-344.
11. Ingram, D., Sanders, K., Kolybaba, M. & Lopez, D. (1997) Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994.
12. Horn-Ross, P. L., John, E. M., Lee, M., Stewart, S. L., Koo, J., Sakoda, L. C., Shiau, A. C., Goldstein, J., Davis, P. & Perez-Stable, E. J. (2001) Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am. J. Epidemiol. 154: 434-441.
13. Brentano, S. T., Picado-Leonard, J., Mellon, S. H., Moore, C.C.D. & Miller, W. L. (1990) Tissue-specific cyclic adenosine 3′,5′-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol. Endocrinol. 4: 1972-1979.
14. Huber, J. C., Schneeberger, C. & Tempfer, C. B. (2002) Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 41 (Suppl.): S55-S64.
15. Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z. & Henderson, B. E. (1998) Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res. 58: 585-587.
16. Kristensen, V. N., Haraldsen, E. K., Anderson, K. B., Lonning, P. E., Erikstein, B., Karensen, R., Gabrielsen, O. S. & Borresen-Dale, A.-L. (1999) CYP17 and breast cancer risk: the polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1. Cancer Res. 59: 2825-2828.
17. Haiman, C. A., Hankinson, S. E., Spiegelman, D., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, K. T. & Hunter, D. J. (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res. 59: 1015-1020.
18. Bergman-Jungestrom, M., Gentile, M., Lundin, A. C. & Wingren, S. (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int. J. Cancer 84: 350-353.
19. Huang, C. S., Chern, H. D., Chang, K. J., Cheng, C. W., Hsu, S. M. & Shen, C. Y. (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 59: 4870-4875.
20. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K. & Henderson, B. E. (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 57: 1063-1065.
21. Dunning, A. M., Healey, C. S., Pharoah, P.D.P., Foster, N., Easton, D. F., Day, N. E. & Ponder, B.A.J. (1998) Polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br. J. Cancer 77: 2045-2047.
22. Helzlsouer, K. J., Huang, H.-Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Comstock, G. W. & Bell, D. A. (1998) Association between CYP17 polymorphism and the development of breast cancer. Cancer. Epidemiol. Biomarkers Prev. 7: 945-949.
23. Weston, A., Pan, C.-F., Bleiweiss, I. J., Ksieski, H. B., Roy, N., Maloney, N. & Wolff, M. S. (1998) CYP17 genotype and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 7: 941-944.
24. Krazelsen, A., Breitling, R., Moller, G. & Adamski, J. (2001) Phytoestrogens inhibit human 17β-hydroxysteroid dehydrogenase type 5. Mol. Cell. Endocrinol. 171: 151-162.
25. Graham, S., Hellmann, R., Marshall, J., Freudenheim, J. L., Vena, J., Swanson, M., Zielezny, M., Nemoto, T., Stubbe, N. & Raimondo, T. (1991) Nutritional epidemiology of postmenopausal breast cancer in Western New York. Am. J. Epidemiol. 134: 552-566.
26. Freudenheim, J. L., Marshall, J. R., Vena, J. E., Laughlin, R., Brasure, J. R., Swanson, M. K., Nemoto, T. & Graham, S. (1996) Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J. Natl. Cancer Inst. 88: 340-348.
27. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Michalek, A. M., Laughlin, R., Nemoto, T., Gillenwater, K., Harrington, A. M. & Shields, P. G. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J. Am. Med. Assoc. 276: 1494-1501.
28. US Department of Agriculture. (1976-1989) Composition of Foods, Agriculture Handbook 8, rev. 8.1-8.17, 8.21. U.S. Government Printing Office Washington, DC.
29. U.S. Department of Agriculture. (1975) Nutritive Value of American Foods in Common Units, Agriculture Handbook 456. U.S. Government Printing Office, Washington, DC.
30. Pillow, P. C., Duphorne, C. M., Chang, S., Contois, J. H., Strom, S. S., Spitz, M. R. & Hursting, S. D. (1999) Development of a database for assessing dietary phytoestrogen intake. Nutr. Cancer 33: 3-19.
31. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novell, P., Franks, S. & Williamson, R. (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 3: 1873-1876.
32. de Kleijn, M.J.J., van der Schouw, Y. T., Wilson, P.W.F., Adlercreutz, H., Mazur, W., Grobbee, D. E. & Jacques, P. F. (2001) Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham Study. J. Nutr. 131: 1826-1832.
33. Thompson, L. U. & Serraino, M. (1990) Lignans in flaxseed and breast and colon carcinogenesis. In: Proceedings of the 53rd Flax Institute, U.S.A., Fargo, ND.
34. Feigelson, H. S., McKean-Cowdin, R., Pike, M. C., Coetzee, G. A., Kolonel, L. N., Nomura, A. M. Y., Le Marchand, L. & Henderson, B. E. (1999) Cytochrome p450c17α gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res. 59: 3908-3910.